Can Bromocriptine therapy influence inflammation markers in patients with chronic illnesses and how might this effect contribute to overall disease management?
Gaurav ChauhanContributor
Can Bromocriptine influence inflammation markers in patients with chronic illnesses?
Share
Bromocriptine has anti-inflammatory properties that may reduce inflammation markers in chronic illnesses, potentially improving disease management and symptom control.
Bromocriptine can reduce inflammation markers such as CRP and TNF-alpha in chronic illnesses, potentially improving disease management by mitigating systemic inflammation.